Table 1. Clinical characteristics for the study subjects.
| Clinical characteristic | GD | Control | P value |
|---|---|---|---|
| Number | 271 | 298 | / |
| Sex (% male) | 25.1% | 22.8% | 0.53 |
| Age (years) | 37.3 ± 15.0 | 41.4 ± 14.7 | 0.001 |
| FT3 (pmol/ml) | 17.0 ± 13.2 | 4.9 ± 0.7 | p < 0.001 |
| FT4 (pmol/ml) | 47.5 ± 27.1 | 17.4 ± 2.1 | p < 0.001 |
| TSH (mIU/L) | 0.2 ± 1.0 | 1.9 ± 0.9 | p < 0.001 |
| TRAB (IU/L) | 12.1 ± 11.3 | 0.5 ± 0.3 | p < 0.001 |
Data are shown as mean ± standard deviation.
FT3: free triiodothyronine; FT4: free thyroxine; TSH: Thyroid Stimulating Hormone; TRAB: TSH Receptor Antibodies; GD: Graves' disease